Source: Sleep and Breathing Conference 2021
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Riha (Edinburgh (Edinburgh), United Kingdom). Effects of pharmacological treatment on residual sleepiness and cognitive functions in OSA patients. Sleep and Breathing Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Assessment and management of OSA patients with cognitive dysfunctions Source: Sleep and Breathing Conference 2021 Year: 2021 Impairment of vigilance during different cognitive processes in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2002; 20: Suppl. 38, 494s Year: 2002 An evaluation of the effects of cognitive behavioural therapy on quality of life and anxiety and depression in COPD patients undergoing pulmonary rehabilitation Source: Eur Respir J 2007; 30: Suppl. 51, 95s Year: 2007 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 227-228 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 227-228 Year: 2012 Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 The links and distinctions between OSA, cognitive fatigue and sleepiness Source: Sleep and Breathing Conference 2021 Year: 2021 Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA) Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 IQ score and cognitive function in obstructive sleep apnoea patients Source: Eur Respir J 2003; 22: Suppl. 45, 92s Year: 2003 Effect of upper airway stimulation for quality of life and sleep architecture in patients with moderate-to-severe OSA Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Sleep quality disturbances and cognitive functioning in elderly patients with COPD Source: ERJ Open Res 2016: 00054-2016 Year: 2016 Impact of cognitive dysfunction and neuro-psychiatric symptoms over quality of life in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea: does excessive daytime sleepiness play a role? Source: Eur Respir J, 53 (1) 1801917; 10.1183/13993003.01917-2018 Year: 2019 Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea: does excessive daytime sleepiness play a role? Source: Eur Respir J, 53 (1) 1802113; 10.1183/13993003.02113-2018 Year: 2019 Functional and clinical correlates of cognitive impairment in obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 254s Year: 2001 Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Treatment for obstructive sleep-disordered breathing improves behavior, cognitive function learning and quality of life Source: Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment Year: 2013